A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension

Sponsor
Innovative Medical (Industry)
Overall Status
Completed
CT.gov ID
NCT00348062
Collaborator
(none)
1

Study Details

Study Description

Brief Summary

Evaluate the incidence of hyperemia in patients using bimatoprost and to determine if simple interventions reduce its incidence and to assess the value of detailed instruction in increasing patient compliance and willingness to continue bimatoprost therapy, despite the occurrence of hyperemia.

Condition or Disease Intervention/Treatment Phase
Phase 4

Study Design

Study Type:
Interventional
Allocation:
Non-Randomized
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Official Title:
A Multicenter Evaluation of Methods to Reduce Hyperemia Associated With Bimatoprost Therapy for Glaucoma or Ocular Hypertension

Outcome Measures

Primary Outcome Measures

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Inclusion Criteria:
    • · Male or female > 18 years of age

    • No prior use of bimatoprost

    • Diagnosis of open-angle glaucoma or ocular hypertension

    • Ability to provide informed consent and likely to complete all study visits

    Exclusion Criteria:
    • · Known contraindication to bimatoprost

    • Uncontrolled systemic disease

    • Active ocular disease other than glaucoma or ocular hypertension

    • Required use of ocular medications other than the study medications during the study (intermittent use of artificial tear solutions will be permitted)

    • History of intraocular surgery within the last 3 months

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Dr. Noecker Pittsburgh Pennsylvania United States 15213

    Sponsors and Collaborators

    • Innovative Medical

    Investigators

    • Principal Investigator: Robert Noecker, MD, UPMC Eye Center

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00348062
    Other Study ID Numbers:
    • 5177
    First Posted:
    Jul 4, 2006
    Last Update Posted:
    Jun 1, 2007
    Last Verified:
    May 1, 2007

    Study Results

    No Results Posted as of Jun 1, 2007